ResMed Inc.RMDNYSE
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank28
Year-over-Year Change
Year-over-year operating cash flow growth rate
Percentile
P28
Within normal range
vs 5Y Ago
-1.4x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -25.71% |
| Q3 2025 | -15.12% |
| Q2 2025 | -6.89% |
| Q1 2025 | 87.50% |
| Q4 2024 | -5.20% |
| Q3 2024 | -26.03% |
| Q2 2024 | 9.47% |
| Q1 2024 | 47.35% |
| Q4 2023 | -4.70% |
| Q3 2023 | 20.57% |
| Q2 2023 | -15.97% |
| Q1 2023 | 119.66% |
| Q4 2022 | 188.02% |
| Q3 2022 | -43.81% |
| Q2 2022 | -32.32% |
| Q1 2022 | -46.59% |
| Q4 2021 | 434.89% |
| Q3 2021 | -128.98% |
| Q2 2021 | 15.41% |
| Q1 2021 | 15.51% |
| Q4 2020 | 18.00% |
| Q3 2020 | -56.40% |
| Q2 2020 | 37.79% |
| Q1 2020 | 242.75% |
| Q4 2019 | -56.93% |
| Q3 2019 | 14.49% |
| Q2 2019 | 1.56% |
| Q1 2019 | 7.86% |
| Q4 2018 | 169.06% |
| Q3 2018 | -62.82% |
| Q2 2018 | -13.19% |
| Q1 2018 | 12.47% |
| Q4 2017 | 41.04% |
| Q3 2017 | -33.02% |
| Q2 2017 | 107.57% |
| Q1 2017 | -43.62% |
| Q4 2016 | 39.02% |
| Q3 2016 | -44.81% |
| Q2 2016 | 27.93% |
| Q1 2016 | -17.15% |